Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pravastatin for polycystic kidney disease
ACTRN12608000447358Phase 4Completed
- Sponsor
- Clifford Craig Foundation
- Start
- Jan 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pravastatin in polycystic kidney disease (PKD) (2 arms), sponsored by Clifford Craig Foundation. Primary endpoint: Serum creatinine. Started Jan 1998; status: completed.
02
Drugs
pravastatin
03
Conditions
polycystic kidney disease (PKD)
Beyond the preview
Go deeper on ACTRN12608000447358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000447358.